End-of-life discussions need skilled and sensitive approach
2010-09-13
(Press-News.org) Health care professionals need sensitivity when delivering the news of a patient's imminent death, states an editorial in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj101201.pdf.
Rather than delegate end of life discussions to inexperienced members of medical teams, these should be delivered by experienced professionals with a network of colleagues who can help in communication and decision-making.
"Without investments in training for all health care professionals and ongoing support for palliative care, we will be "caring" for patients and families who feel abandoned, angry or overwhelmed by feelings of hopelessness," write guest author Dr. David Kuhl, St. Paul's Hospital with Dr. Matthew Stanbrook, Deputy Editor, CMAJ and CMAJ Editor-in-Chief Dr. Paul Hebert. "With proper support, awareness and training all of us have the ability to connect with terminally ill patients and their loved ones so that they feel sustained, rather than abandoned, at a time of great need."
INFORMATION: END
ELSE PRESS RELEASES FROM THIS DATE:
2010-09-13
Hutchinson-Gilford Progeria Syndrome (HGPS or progeria) is a rare genetic disease that causes young children to develop symptoms associated with advanced age, such as baldness, wrinkles, osteoporosis and cardiovascular disease. Now, a study published by Cell Press in the September 14th issue of the journal Developmental Cell uses a mouse model to shed light on progeria, and perhaps also on the normal aging process.
Progeria is caused by a mutation in the gene for lamin A that leads to production of "progerin", a truncated form of the lamin A protein that causes the cell ...
2010-09-13
African Americans with muscular dystrophy die 10 to 12 years younger than their white counterparts, according to research published in the Sept. 14 issue of Neurology, the medical journal of the American Academy of Neurology.
The black-white mortality gap, which was calculated on the basis of 20 years of data, is among the largest ever observed in the annals of research into racial disparities in health care, say Dr. Nicte Mejia and Dr. Rachel Nardin, co-authors of the editorial. "Furthermore," they write, "white patients with MD [muscular dystrophy] enjoy increasing ...
2010-09-13
Smokeless tobacco products should not be used as an alternative to cigarettes or for smoking cessation due to the risk of addiction and return to smoking, according to an American Heart Association policy statement.
Smokeless tobacco products such as dry and moist snuff as well as chewing tobacco may also increase the risk of fatal heart attack, fatal stroke and certain cancers, according to the statement published online in Circulation: Journal of the American Heart Association.
"No tobacco product is safe to consume," said Mariann Piano, Ph.D., lead writer of the ...
2010-09-13
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a common genetic disease that results in chronic kidney failure. Although the genes responsible for ADPKD have been identified (PKD1, PKD2), relatively little is known about how mutations in these genes promote cyst growth molecularly. In this paper, scientists at Children's Hospital in Boston, lead by Jordon Kreidberg, investigated the signaling pathways that go awry in the disease using mouse kidney epithelial cells in which Pkd1 was genetically deleted. They found that the protein c-Met was hyperactive in Pkd1-deficient ...
2010-09-13
Myeloproliferative neoplasms (MPN) comprise a family of blood cancers characterized by clonal expansion of a single blood cell type. Untreated, these cancers can progress to bone marrow failure and acute myeloid leukemia. Several groups have identified activating mutations in the JAK2 gene as associated with MPN; JAK2 inhibition has therefore emerged as approach to MPN therapy. Thus far, however, JAK2 inhibition strategies have had limited efficacy and have been accompanied by significant toxicity. In this paper, Ross Levine and his group at the Memorial Sloane Kettering ...
2010-09-13
EDITOR'S PICK
Hi-JAK-ing Cancer by Inhibiting Jak2
Myeloproliferative neoplasms (MPN) comprise a family of blood cancers characterized by clonal expansion of a single blood cell type. Untreated, these cancers can progress to bone marrow failure and acute myeloid leukemia. Several groups have identified activating mutations in the JAK2 gene as associated with MPN; JAK2 inhibition has therefore emerged as approach to MPN therapy. Thus far, however, JAK2 inhibition strategies have had limited efficacy and have been accompanied by significant toxicity. In this paper, Ross ...
2010-09-13
Researchers reveal a new way in which cells restrain beta-catenin and potentially suppress tumor metastasis: the protein can be ejected from cells in small vesicles called exosomes. The study appears online on September 13 in the Journal of Cell Biology (www.jcb.org).
Beta-catenin is a central component of the Wnt signaling pathway that controls cell proliferation and differentiation. Activation of the Wnt pathway stabilizes beta-catenin, allowing it to move into the cell nucleus and control the expression of many different genes.
Michael Caplan's group at Yale University ...
2010-09-13
Heart enlargement caused by narrowed aortic valves regresses faster in elderly women than in men after aortic valve replacement, according to research reported in a surgical supplement of Circulation: Journal of the American Heart Association.
Men's slower heart-size regression times may be attributable to genetic differences that cause the heart to develop more fibrous tissue after surgery because of narrowed heart valves, a condition known as aortic stenosis.
"We show for the first time that elderly women and men differ in their gene expression related to fibrous ...
2010-09-13
An international team of scientists and physicians used a combination of sophisticated emerging technologies and data analysis to detect 14 simple metabolites with high accuracy to predict in early pregnancy which women are at risk of developing preeclampsia in later pregnancy, according to a study reported in Hypertension: Journal of the American Heart Association. Currently there is no predictive test for the condition and no cure other than delivery of the baby.
Preeclampsia is a life-threatening condition characterized by high blood pressure and high levels of protein ...
2010-09-13
Publicly available information about board certification, education and malpractice claims appear to provide consumers with little information about the quality of care individual physicians provide, according to a report in the September 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
"To improve the quality of care received by their beneficiaries, some health plans use physician report cards and tiered physician networks to steer their members toward physicians who provide high-quality care. However, most patients do not have access to ...
LAST 30 PRESS RELEASES:
[Press-News.org] End-of-life discussions need skilled and sensitive approach
